Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
Brings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes.
Brings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes.
Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.
Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.
A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
Mesoblast generates impressive gains over Christmas.
Mesoblast generates impressive gains over Christmas.
Treatment could help improve blood flow and decrease tissue death in individuals with diabetes.
Treatment could help improve blood flow and decrease tissue death in individuals with diabetes.
First patient to receive Living Cell Technology's Diabcell implant has reduced insulin dose.
First patient to receive Living Cell Technology's Diabcell implant has reduced insulin dose.
With New Zealand government recently opening the door to xenotransplantation trials – it is time for the Australian government to reconsider its moratorium.
With New Zealand government recently opening the door to xenotransplantation trials – it is time for the Australian government to reconsider its moratorium.
Professor Michael Cowley awarded 2009 Science Minister’s Prize for Life Scientist of the Year for work on obesity and diabetes.
Professor Michael Cowley awarded 2009 Science Minister’s Prize for Life Scientist of the Year for work on obesity and diabetes.
Living Cell Technologies opens pig breeding facility ahead of xenotransplantation trials to treat type 1 diabetes.
Living Cell Technologies opens pig breeding facility ahead of xenotransplantation trials to treat type 1 diabetes.
Hormone adiponectin could be used to better diagnose and treat type 2 diabetes.
Hormone adiponectin could be used to better diagnose and treat type 2 diabetes.
Calls for Australian Government to lift moratorium on xenotransplantation so similar trials can occur here.
Calls for Australian Government to lift moratorium on xenotransplantation so similar trials can occur here.
T-cell breakthrough could lead to immune boosting treatments
T-cell breakthrough could lead to immune boosting treatments
LCT receives govt approval to trial DiabeCell porcine islets in NZ
LCT receives govt approval to trial DiabeCell porcine islets in NZ
The Sydney Project aims to have human embryonic stem cells in clinical trials to treat type 1 diabetes in four years.
The Sydney Project aims to have human embryonic stem cells in clinical trials to treat type 1 diabetes in four years.
